BRIEF-Quoin Pharmaceuticals Completes Establishment Of Japanese Subsidiary To Advance Commercial Readiness For Qrx003

June 18 (Reuters) - Quoin Pharmaceuticals Ltd 2EB0y.F:

  • QUOIN PHARMACEUTICALS COMPLETES ESTABLISHMENT OF JAPANESE SUBSIDIARY TO ADVANCE COMMERCIAL READINESS FOR QRX003

  • QUOIN PHARMACEUTICALS - TO INITIATE PHASE 3 STUDY FOR QRX003 IN H2 2026 WITH POTENTIAL NDA FILING IN 2027

Source text: ID:nGNX3M1qSH

Further company coverage: [2EB0y.F]


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.